HIV-1 Tat: Molecular Switch in Viral Persistence and Emerging Technologies for Functional Cure
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136311 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kaixin Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen Uni…. Hauptthemen laut MEDLINE: HIV-1, tat Gene Products, Human Immunodeficiency Virus, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Shenzhen Key Laboratory of Systems Medicine.
Abstract (Originalsprache)
HIV-1 Tat acts as a central molecular switch governing the transition between viral latency and active replication, making it a pivotal target for HIV-1 functional cure strategies. By binding to the viral long terminal repeat (LTR) and hijacking host transcriptional machinery, Tat dynamically regulates RNA polymerase II processivity to alter viral transcription states. Recent studies reveal its context-dependent variability: while Tat recruits chromatin modifiers and scaffolds non-coding RNAs to stabilize epigenetic silencing in latently infected cells, it also triggers rapid transcriptional amplification upon cellular activation. This review systematically analyzes the bistable regulatory mechanism of Tat and investigates advanced technologies for reprogramming this switch to eliminateviral reservoirs and achieve functional cures. Conventional approaches targeting Tat are limited by compensatory viral evolution and poor bioavailability. Next-generation interventions will employ precision-engineered tools, such as AI-optimized small molecules blocking Tat-P-TEFb interfaces and CRISPR-dCas9/Tat chimeric systems, for locus-specific LTR silencing or reactivation (“block and lock” or “shock and kill”). Advanced delivery platforms, including brain-penetrant lipid nanoparticles (LNPs), enable the targeted delivery of Tat-editing mRNA or base editors to microglial reservoirs. Single-cell multiomics elucidates Tat-mediated clonal heterogeneity, identifying “switchable” subpopulations for timed interventions. By integrating systems-level Tat interactomics, epigenetic engineering, and spatiotemporally controlled delivery, this review proposes a roadmap to disrupt HIV-1 persistence by hijacking the Tat switch, ultimately bridging mechanistic insights to clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China.
ORCID-Profile: Ting Pan
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Shenzhen Key Laboratory of Systems Medicine
- Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases
Zitieren
APA
Yu, K., Liu, H., & Pan, T. (2025). HIV-1 Tat: Molecular Switch in Viral Persistence and Emerging Technologies for Functional Cure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136311
Vancouver
Yu K, Liu H, Pan T. HIV-1 Tat: Molecular Switch in Viral Persistence and Emerging Technologies for Functional Cure. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136311
BibTeX
@article{Yu2025,
author = {Yu, Kaixin and Liu, Hanxin and Pan, Ting},
title = {HIV-1 Tat: Molecular Switch in Viral Persistence and Emerging Technologies for Functional Cure},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136311}
}
EUVIMED